Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.34304
Abstract: The outcomes and best treatment strategies for germline BRCA1/2 mutation (gBRCAm) carriers with metastatic breast cancer (MBC) remain uncertain. We compared the overall survival and the first line progression free survival (PFS1) of patients with… read more here.
Keywords: germline brca1; survival; status; metastatic breast ... See more keywords